BIGNUCOLO, ALESSIA
 Distribuzione geografica
Continente #
AS - Asia 202
NA - Nord America 85
EU - Europa 51
SA - Sud America 30
AF - Africa 8
Totale 376
Nazione #
SG - Singapore 133
US - Stati Uniti d'America 81
CN - Cina 37
VN - Vietnam 24
BR - Brasile 22
IT - Italia 19
NL - Olanda 11
HK - Hong Kong 6
GB - Regno Unito 5
AR - Argentina 4
FR - Francia 4
GH - Ghana 4
AT - Austria 3
IE - Irlanda 3
ZA - Sudafrica 3
CA - Canada 2
EC - Ecuador 2
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
DE - Germania 1
ES - Italia 1
ID - Indonesia 1
IN - India 1
JM - Giamaica 1
LT - Lituania 1
MX - Messico 1
PY - Paraguay 1
RU - Federazione Russa 1
SE - Svezia 1
Totale 376
Città #
Singapore 45
Beijing 25
Ashburn 17
Dallas 12
Redondo Beach 11
Ho Chi Minh City 10
Los Angeles 9
Amsterdam 7
Buffalo 7
Hong Kong 6
Accra 4
Hanoi 4
New York 4
Palermo 4
Dublin 3
Milan 3
Vienna 3
Can Tho 2
Denver 2
Johannesburg 2
Lauterbourg 2
London 2
Messina 2
Phoenix 2
Poplar 2
Sorocaba 2
São Paulo 2
Abidjan 1
Almirante Tamandaré 1
Araçariguama 1
Araçatuba 1
Atlanta 1
Barbacena 1
Bauru 1
Belo Horizonte 1
Bexley 1
Biên Hòa 1
Boardman 1
Boston 1
Campinas 1
Canoas 1
Cape Town 1
Charlotte 1
Chennai 1
Chicago 1
Dourados 1
Duque de Caxias 1
Formosa 1
Frankfurt am Main 1
Guayaquil 1
Haiphong 1
Hải Dương 1
Imperatriz 1
Ji Paraná 1
Kingston 1
Manassas 1
Martínez 1
Mascalucia 1
Matheu 1
Mexico City 1
Miguelópolis 1
Montreal 1
Moscow 1
Orem 1
Paris 1
Pereira Barreto 1
Petrópolis 1
Quito 1
Quận Bình Thạnh 1
San Justo 1
Santa Clara 1
Santiago 1
Serra 1
Sofia 1
Stockholm 1
The Dalles 1
Toronto 1
Urucará 1
Uruguaiana 1
Vĩnh Tường 1
Totale 247
Nome #
Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina 74
Oxidative Stress by H2O2 as a Potential Inductor in the Switch from Commensal to Pathogen in Oncogenic Bacterium Fusobacterium nucleatum 34
Implementing fencing as adapted physical activity in non-metastatic breast cancer patients: design and early rehabilitation strategy of the FENICE study protocol 28
Multidisciplinary Integrative Medicine Approach for Cancer Patients: A Multicenter Retrospective Study 24
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study 20
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 17
Impact of Vitamin D Levels on Progression-Free Survival and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis 17
Genetic biomarkers for hepatocellular cancer risk in a caucasian population 15
Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results 15
Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study 15
Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer 15
Il15ra and smad3 genetic variants predict overall survival in metastatic colorectal cancer patients treated with folfiri therapy: A new paradigm 14
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients 13
Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand? 13
Genetic markers of the host to predict the efficacy of colorectal cancer targeted therapy 13
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment 13
Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC 13
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI 12
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy 12
Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers 12
Sex disparities in efficacy in covid-19 vaccines: A systematic review and meta-analysis 6
Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation 4
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy 4
Totale 403
Categoria #
all - tutte 1.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.269


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 0 0 0 0 0 0 3 0 3
2024/202553 5 4 0 3 3 6 6 2 9 4 6 5
2025/2026344 71 44 57 60 103 9 0 0 0 0 0 0
Totale 403